NLRP3 and eosinophilic esophagitis: Importantly, we present direct evidence that IL-18 neutralization or IL-18 deficiency in mice restricts the formation of most of the pathological characteristics observed in EoE, and that treatment with NLRP3 or caspase1 inhibitors protects mice from developing aeroallergen or food allergen-induced EoE.